JNJ-46281222

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameJNJ-46281222
Drug Alias NameJNJ-46281222
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action +[1]  N/A
TargetsMetabotropic glutamate receptor 2
Therapy Area/IndicationsPsychotic Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesJohnson & Johnson
Inactive CompaniesN/A
Active IndicationsPsychotic Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A